| Posted at 12:51 PM on Apr 19, 2008 by concernedcitizen, #29732 |
My son had severe tantrums around dinner time and he would finally admit that he was hungry. He also thought he was hungry all the time. This ended up being tied into his ADHD and being on the meds for that, that suppress the appetite seemed to "cure" it. I have noticed he is not as famished when we do not use the ADHD meds since he has been off of the singulair. Could it be possible that because of the neuron damage, these kids develop ADHD symptoms? My son has no problem paying attention but struggles with impulsivity, hyperactivity, and irrational behavior, labeling him as ADHD. Please tell me what you think. He started singulair at age 4 and I have taken him off at age 8. That is a young brain! Thanks for all of your info!
I know that people think that I am picking on Merck. There is quite a trend that the FDA approves a lot of drugs for which there are not adequate answers. I am going to look at Lilly's Cymbalta. The literature says that they don't know how it works. Yeh, right on the patient information sheet. Then they list a lot of side effects that are similar to Singulair. Why would anybody take a drug that the company doesn't know anything about?
I want to take a look. It might take a few days to see if there are any parallels.
Thanks concernedcitizen for the informative information about Singulair. I have read alot of your postings and wasn't aware of the actions of the drug. You are either very knowledgable or have done some great research.
neuron activity nerve cells nervous system disease nerve damage areas of the brain chinese researchers endothelial cells rat brain brain tissue effects of hypoglycemia hypoglycemics central nervous system behavioral response brain damage human brain montelukast nmda synaptic cleft behavior studies glial adhd symptoms irrational behavior famished singulair dinner time tantrums neuron hyperactivity adhd paying attention appetite brain patient information sheet adequate answers cymbalta parallels merck lilly few days fda literature drugs postings great research